Skip to main content

Table 2 Cases characteristics

From: A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group

Demographic characteristics 

N

%

Total cases

30

(100%)

Sex

 Male

19

(63%)

 Female

11

(37%)

Age at study referral

 65 – 69

9

(30%)

 70 – 74

8

(27%)

 75 – 79

8

(27%)

 80 + 

5

(16%)

Status

 Alive

9

(30%)

 Dead

21

(70%)

Referral characteristics

N

%

Referral specialty

 Ann Rowling Clinic

15

(50%)

 Neurology

4

(13%)

 Psychiatry of Old Age

8

(27%)

 Medicine of the Elderly

3

(10%)

Interval between onset of symptoms and referral to the study

Mean = 7 years (1 – 13 years, std dev 4.1)

By age group

 65 – 69

Mean = 8 years (2 – 13 years, std dev 4.5)

 70 – 74

Mean = 6 years (3 – 11 years, std dev 3.4)

 75 – 79

Mean = 8 years (1 – 13 years, std dev 4.5)

 80 + 

Mean = 5 years (2 – 10 years, std dev 3.3)

Clinical characteristics

N

%

Age at onset of symptoms

Mean = 66 years (53 – 82 years, std dev. 7.8)

Suspected diagnosis

  

 Atypical Alzheimer's Disease

11

(37%)

 Frontotemporal dementia

4

(13%)

 Mixed a

6

(20%)

 Unclear/unknown

9

(30%)

CJD-consistent features b

 Cerebellar ataxia

14

(47%)

 Involuntary movements

8

(27%)

 Rapid progression

7

(23%)

 Sensory features

2

(7%)

 Visual disturbance

1

(3%)

Duration of illness (from the onset of symptoms to censor date/death)

Mean = 9.5 years (1.1 – 17.4 years, std dev 4.7)

Symptoms

a) Forgetfulness/ memory impairment

28

(93%)

b) Visuospatial difficulties (in recognising objects, familiar people, reading difficulties)

22

(73%)

c) Executive dysfunction (impaired problem solving/judgement)

29

(97%)

d) Language disturbance

 Receptive

18

(60%)

 Expressive

26

(87%)

e) Psychiatric symptoms

 Depression

24

(80%)

 Anxiety

19

(63%)

 Delusions

6

(20%)

 Behavioural disturbance

20

(67%)

 Impulsive/socially inappropriate

14

(47%)

 Change in food preferences

12

(40%)

 Aggressive

10

(33%)

 Lacking in empathy

14

(47%)

 Repetitive movements/behaviours

17

(57%)

 Apathy/ withdrawal

21

(70%)

f) Hallucinations

 Visual

8

(27%)

 Audio

3

(10%)

g) No insight

16

(53%)

h) Disturbance of gait

21

(70%)

i) Bedbound

3

(10%)

j) Dysarthria

10

(33%)

k) Visual Impairment

3

(10%)

l) Fluctuations of symptoms

3

(10%)

m) Weakness of limbs

6

(20%)

n) Clumsiness of limbs

9

(30%)

o) Slowness of movement

18

(60%)

p) Apraxia

23

(77%)

q) Involuntary movements

 Tremor

18

(60%)

 Jerking

12

(40%)

 Dystonia

0

0

 Alien limb

1

(3%)

r) Seizures

4

(13%)

 Akinetic mutism

0

0

t) Sensory symptoms

 Numbness/tingly/paraesthesia

5

(17%)

 Pain/burning/discomfort)

3

(10%)

Other relevant histories

N

%

Surgical history (including transplant)

 No surgery

2

7%

 1 – 2

10

33%

 3 – 4

9

30%

 5 + 

9

30%

Blood transfusion history c

 No

29

97%

 Yes

1

3%

Previous injections d

  

 No

24

80%

 Yes

6

20%

Family history of dementia

 No

14

47%

 Yes

13

43%

 Unsure/unclear/not known

3

10%

Occupation history

  

 High-risk occupations e

7

23%

 Other

23

77%

  1. a mixed: early-onset Alzheimer’s Disease / vascular dementia (3 cases); Corticobasal syndrome/ Progressive supranuclear palsy (1); Frontotemporal dementia /vascular (1)
  2. b some cases presented with more than one feature
  3. c including blood components or plasma products e.g., immunoglobulins or albumins
  4. d as part of treatment e.g., human growth hormone, human gonadotrophin, insulin, fertility treatment
  5. e included: healthcare professions in medical, dentistry, nursing, and paramedical. Laboratory-based professions that dealt with animals, pharmaceutical, or other related research. Professions in veterinary medicine, animal farming, and the meat industry
  6. Note: Std dev is standard deviation